Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Reno. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Reno at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
The purpose of this study is to determine if RRx-001, which is added on to the cisplatin and radiation treatment, reduces the incidence of severe oral mucositis in patients with head and neck cancers. All patients in this study will receive 7 weeks of standard of care radiation therapy given with the chemotherapy agent, cisplatin. Patients will receive RRx-001 or placebo before start of standard of care treatment.
Sponsor: EpicentRx, Inc.
Check if you qualify for this head and neck cancer clinical trial in Reno, NV
If you're searching for head and neck cancer treatment options in Reno, NV, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Reno research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.